In this video Dr John Marshall of Georgetown University, and Professor John Primrose of the University of Southampton, discuss the practice-changing findings of the BILCAP study which investigated adjuvant capecitabine for biliary tract cancer (cholangiocarcinoma). The pan-European study that Professor Primrose refers to (6:09 into the interview) is the ACTICCA-1 trial.